Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This study will evaluate the safety and efficacy of combination treatment with grazoprevir + elbasvir for compensated cirrhotic participants with chronic genotype 1 (GT1) and genotype 6 (GT6) hepatitis C virus (HCV) infection with or without human immunodeficiency virus (HIV) infection.
Epistemonikos ID: 5e6b305b1c93952c2135a6ca66bee51a282d6e60
First added on: May 20, 2024